Evidence map›Paper›PMID 18371447›Full record

ArticleCell stem cell2008

MicroRNA regulation of cell lineages in mouse and human embryonic stem cells.

Kathryn N Ivey, Alecia Muth, Joshua Arnold, Frank W King, Ru-Fang Yeh, Jason E Fish, Edward C Hsiao, Robert J Schwartz, Bruce R Conklin, Harold S Bernstein and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell stem cell, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 290 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
290citing papers in PubMed, 1 pooled it
20.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

290 citing papers in PubMed, 1 synthesis or guideline pooled it, 602 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Impact ofJournal of cardiovascular development and disease · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. NamiRNA-Enhancer Network: The Changing Era Challenge and Chance of miRNA.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  9. Article
  10. Review
  11. The molecular mechanisms of cardiac development and related diseases.Signal transduction and targeted therapy · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cripto Is Targeted by miR-1a-3p in a Mouse Model of Heart Development.International journal of molecular sciences · 2023
    Article
  18. Review
  19. Article
  20. Review

230 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Kathryn N IveyGladstone Institute of Cardiovascular Disease, University of California, San Francisco, 1650 Owens Street, San Francisco, CA 94158, USA.
Alecia Muth
Joshua Arnold
Frank W King
Ru-Fang Yeh
Jason E Fish
Edward C Hsiao
Robert J Schwartz
Bruce R Conklin
Harold S Bernstein
Deepak Srivastava
Gladstone Institutes · USUniversity of California, San Francisco · USTexas A&M Health Science Center · US

Funding

CARDIOGENESIS--MOLECULAR MECHANISMSR01HL057181 · NHLBI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI DEEPAK SRIVASTAVA · 1997 to 2026
$14.0M
Training in Developmental Cardiovascular BiologyT32HL007544 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SRIVASTAVA, DEEPAK · 1985 to 2021
$4.5M
EXTRAMULAR RESEARCH FACILITIES CONSTRUCTIONC06RR018928 · NCRR · J. DAVID GLADSTONE INSTITUTES · PI MAHLEY, ROBERT W. · 2003 to 2003
$2.1M
Stem Cell Differentiation for Myocardial TherapyR21HL085377 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BERNSTEIN, HAROLD S · 2007 to 2008
$424k
NCRR NIH HHS C06 RR018928NCRR NIH HHS C06RR018928NHLBI NIH HHS HL007544NHLBI NIH HHS HL085377NHLBI NIH HHS R01 HL057181NHLBI NIH HHS R21 HL085377NHLBI NIH HHS T32 HL007544
6 · The paper itself

Abstract

Cell fate decisions of pluripotent embryonic stem (ES) cells are dictated by activation and repression of lineage-specific genes. Numerous signaling and transcriptional networks progressively narrow and specify the potential of ES cells. Whether specific microRNAs help refine and limit gene expression and, thereby, could be used to manipulate ES cell differentiation has largely been unexplored. Here, we show that two serum response factor (SRF)-dependent muscle-specific microRNAs, miR-1 and miR-133, promote mesoderm formation from ES cells but have opposing functions during further differentiation into cardiac muscle progenitors. Furthermore, miR-1 and miR-133 were potent repressors of nonmuscle gene expression and cell fate during mouse and human ES cell differentiation. miR-1's effects were in part mediated by translational repression of the Notch ligand Delta-like 1 (Dll-1). Our findings indicate that muscle-specific miRNAs reinforce the silencing of nonmuscle genes during cell lineage commitment and suggest that miRNAs may have general utility in regulating cell-fate decisions from pluripotent ES cells.

Indexed as

AnimalsCell DifferentiationCell LineageEmbryonic Stem CellsGene Expression Regulation, DevelopmentalHumansMesodermMiceMice, TransgenicMicroRNAsMyocardiumPluripotent Stem CellsMicroRNAs

Identifiers

PMID18371447
PMCPMC2293325
OpenAlexW2115094273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.